| Overview |
| bsm-62098r-pe-cy7-100ul |
| MAP3K7IP3 Recombinant Monoclonal Antibody, PE-Cy7 Conjugated |
| WB |
| Human, Mouse |
| Specifications |
| PE-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TAB3 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 257397 |
| Q8N5C8 |
| Extracellular, Cytoplasm, Cell membrane |
| MAP3K7IP 3; NAP1; NFkB activating protein 1; Tab3; TAK1 binding protein 3. |
| Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz